Update on non-executive director appointment

September 30, 2019

Download full announcement

Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that it expects to appoint an additional non-executive director and healthcare industry veteran within the coming weeks.

A qualified candidate has been identified to the Company and the process of completing regulatory due diligence is nearing completion. Further announcements will be made at the appropriate time.


Enquiries

Renalytix AI plc www.renalytixai.com
James McCullough, CEO Via Walbrook PR or
Tel: +1 646 397 3970
   
Stifel (Nominated Adviser & Joint Broker) Tel: 020 7710 7600

Alex Price / Jonathan Senior / Ben Maddison (Investment Banking)
Peter Lees (Corporate Broking)

 
   
N+1 Singer (Nominated Adviser & Broker) Tel: 020 7496 3000
Aubrey Powell / James White / George Tzimas (Corporate Finance)
Tom Salvesen / Mia Gardner (Corporate Broking)
 
   
Walbrook PR Limited Tel: 020 7933 8780
renalytix@walbrookpr.com
Paul McManus
Lianne Cawthorne
Mob: 07980 541 893
07584 391 303